gms | German Medical Science

27th German Cancer Congress Berlin 2006

German Cancer Society (Frankfurt/M.)

22. - 26.03.2006, Berlin

Ultraradical resection of thyroid carcinoma: surgical heroism or multilation?

Meeting Abstract

  • corresponding author presenting/speaker Markus Dürsch - Universitätsklinikum, Erlangen, Deutschland
  • B. Reingruber - Universitätsklinikum, Erlangen
  • W. Hohenberger - Universitätsklinikum, Erlangen

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO253

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dkk2006/06dkk363.shtml

Published: March 20, 2006

© 2006 Dürsch et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

In medullary thyroid carcinoma, surgery is the only validated therapeutic option. We report the case of a 12 year old girl with a metastatic and locally advanced medullary thyroid carcinoma. At the time of presentation, the patient had severe obstructive respiratory failure due to a thyroid tumor which had grossly infiltrated a long tracheal segment, both recurrent nerves and the esophagus. Furthermore, large bilateral cervical lymph node metastases reached up to the base of the skull. In July 2004 we performed a multivisceral resection of the thyroid including a 4cm segment of the trachea, the recurrent nerves, the anterior esophageal wall and an extended radical bilateral neck dissection. Additionally, a tracheostomy and a gastrostomy had to be created. Macroscopically, the tumor could cmpletely resected. Histopathological staging revealed a medullary thyroid carcinoma UICC IV (pT4, pN1 (56/82), L1, V0, M0, R1). The girl was included in an experimental study protool of a combined high dose radio-chemotherapy. She has been followed up in 3 monthly intervals and has no evidence of residual disease or recurrence today, 18 months after surgery. With view to her permanent functional impairments we will discuss whether this ultra-radical surgical approach is justifiable.